Switch to:

Castle Biosciences Additional Paid-In Capital

: $210.62 Mil(As of Jun. 2020)
View and export this data going back to 2019. Start your Free Trial

Castle Biosciences's quarterly additional paid-in capital increased from Dec. 2019 ($137.31 Mil) to Mar. 2020 ($139.56 Mil) and increased from Mar. 2020 ($139.56 Mil) to Jun. 2020 ($210.62 Mil).

Castle Biosciences's annual additional paid-in capital increased from Dec. 2017 ($0.81 Mil) to Dec. 2018 ($0.92 Mil) and increased from Dec. 2018 ($0.92 Mil) to Dec. 2019 ($137.31 Mil).


Castle Biosciences Additional Paid-In Capital Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
Additional Paid-In Capital 0.81 0.92 137.31

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Additional Paid-In Capital Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.91 136.59 137.31 139.56 210.62

Castle Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Castle Biosciences Additional Paid-In Capital Related Terms


Castle Biosciences Additional Paid-In Capital Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)